02 Nov HEFFTER CELEBRATES 20TH ANNIVERSARY; NEARLY $4 MILLION OF PSYCHEDELIC RESEARCH FUNDED
The Heffter Research Institute celebrates its 20th anniversary in November 2013. In those 20 years we have provided nearly $4 million in support of the following research programs:
- Use of psilocybin in obsessive compulsive disorder (Dr. Francisco Moreno at the University of Arizona)
- Psilocybin in the treatment of depression and anxiety in terminal cancer patients (Dr. Charles Grob at Harbor-UCLA Medical Center)
- Study of psilocybin in the treatment of anxiety and depression resulting from a life-threatening cancer diagnosis (Dr. Roland Griffiths at Johns Hopkins University)
- Psilocybin in the treatment of anxiety and psychosocial distress in cancer patients (Dr. Stephen Ross, Dr. Jeffrey Guss and Dr. Anthony Bossis at New York University)
- Psilocybin in the treatment of alcoholism (Dr. Michael Bogenschutz at the University of New Mexico)
- Psilocybin in the treatment of cigarette smoking addiction (Dr. Matthew Johnson at Johns Hopkins University)
- Psilocybin and Spirituality (Dr. Roland Griffiths at Johns Hopkins University)
- Studies of the effect of psilocybin on brain functions mediating the experience of self and emotion regulation (Dr. Franz Vollenweider at the Heffter-Zürich Research Center, University of Zürich, Switzerland)
- Studies of the molecular effects of psychedelics on gene expression in the brain, as well as their powerful anti-inflammatory properties (Dr. Charles Nichols at Louisiana State University Health Sciences Center, New Orleans)
- Effects of psilocybin on behavior, psychology, and brain function in long-term meditators (Dr. Roland Griffiths at Johns Hopkins University)
- Qualitative interview study of patient experiences of psilocybin treatment and psycho-educational sessions (Dr. Stephen Ross and Dr. Alex Belser at New York University)
The Heffter Institute is a non-profit organization that was founded by a leading group of brain scientists, and remains the only neuroscience institute dedicated to supporting research with psychedelic substances in order to contribute to a greater understanding of the mind, improvement of the human condition, and the alleviation of suffering.
For more information, please contact: Cibele Ruas, [email protected].